Research Article | Open Access
Volume 2023 - 2 | Article ID 229 | http://dx.doi.org/10.51521/WJCRCI.2023.220128
Academic Editor: John Bose
Vargas Gismondi A. MD1, García-Ríos Luis E. MD2 , Luna-Castillo Marisol
MD3, Medrano-Guzmán Rafael MD4,
Mantilla-Morales Alejandra MD5,
García Avila Ana K. MD6, Vargas Odar
Maria J. UGS.
1,2,3,4,6Oncology
hospital, Surgical Oncology Department, Division of Soft Tissue, Bone and Digestive Tract Tumors, 21st Century National Medical Center IMSS, Mexico
City, Mexico.
5Oncology Hospital,
Pathology Department, 21st Century National Medical Center IMSS, Mexico City,
Mexico.
UGS Washington and Lee University, Virginia, USA.
Corresponding
Author: Vargas Gismondi Alberto M.D. Surgical
Oncology Department, Division of Soft Tissue, Bone and Digestive Tract Tumors,
Centro Médico Nacional “Siglo XXI” IMSS, Mexico City, 05300,
Citation: Vargas Gismondi A. MD, García-Ríos Luis E. MD, Luna-Castillo Marisol MD, Medrano-Guzmán Rafael MD, Mantilla-Morales Alejandra MD, García Avila Ana K. MD, Vargas Odar Maria J. UGS. (2023) Assessment of the Relapse Patterns Following Surgical Resection of Adenocarcinoma of the Ampulla of Vater in a Third Level Care Hospital: A 5 Years Analysis World J Case Rep Clin Imag. 2023 October-November; 2(2)1-6.
Copyrights © 2023, Vargas Gismondi A. MD. This article is licensed under the Creative Commons Attribution-Non-Commercial-4.0-International-License-(CCBY-NC) (https://worldjournalofcasereports.org/blogpage/copyright-policy). Usage and distribution for commercial purposes require written permission
ABSTRACT
Background:
Relapse of
adenocarcinoma of ampulla of Vater (CAV)
and its presentation after surgery continues to be a main issue and its
patterns is unknown in our population.
Objectives:
To describe
the relapse patterns after radical surgery and to identify the associated risk
factors in a mexican population at a Tertiary Care
Center.
Methods: Retrospective Study. Patients with CAV
who underwent surgery from January 2016 to December of 2020. Relapse:
demonstrable disease by means of radiological studies after 3 months of
surgery. Main outcomes: patterns of relapse and associated clinical and
pathological factors.
Results: 72 patients CAV included. Relapse
developed in 50% (36), 21 men (58.3%), mean age 60 years (range, 56.9 to 63),
18 in clinical stage III (50%), the procedure mostly performed: Traverso 29
(80.6%), the mean procedure duration: 353 minutes and surgical mortality 9.7%.
Pancreatic fistula 33.3 % of relapse. CAV relapse: Regional lymph node 19.4%,
liver metastasis 52.8%, lung metastasis 27.8%. Mean survival in each relapse
pattern: pulmonary metastasis 27.5 months, liver metastasis 25.4 months and
lymph nodes metastasis 23.6 months with P=0.002 (95% CI). Mean survival for local
relapse 23.6 months and for distant relapse 25.9 months (95%, CI), P=0.29.
Identified pancreatic fistula as independent risk factor associated with
relapse (HR=2.4, 1.16-4.96, P=0.02).
Conclusions:
Relapse
patterns: liver (52.8%), pulmonar (27.8%) and regional lymph nodes (19.4%) of
which regional lymph node relapse seems to have the worst survival prognosis.
Pancreatic fistula was related to relapse and survival deterioration. Local or
systemic recurrence have similar prognosis.
Keywords:
Adenocarcinoma, Ampulla of Vater,
Fistula, Metastasis, Prognosis